A loxP site and a frt-flanked neomycin resistance cassette were inserted between exons 3 and 4, and a second loxP site was inserted between exons 11 and 12. Founder mice were crossed to a transgenic strain expressing Flp recombinase (Tg(ACTFLPe)9205Dym mice) to remove the neomycin cassette and leave exons 4 through 11 flanked by loxP sites. Southern blot and PCR analyses on genomic DNA confirmed that the correct targeting and recombinase events occurred. (J:140018)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count